We thank the study participants and local staff from Yingjiang CDC and Menglian CDC for their contribution of time and effort. We thank the staff members of the Division of Malaria Research, University of Maryland, for administrative and logistical support.
World Health Organization, 2015. Global Technical Strategy for Malaria 2016–2030. Geneva, Switzerland: WHO.
Xu J, Liu H, 2012. The challenges of malaria elimination in Yunnan Province, People’s Republic of China. Southeast Asian J Trop Med Public Health 43: 819–824.
malERA, 2011. A research agenda for malaria eradication: drugs. PLoS Med 8: e1000402.
Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, O’Meara W, Price RN, Riley EM, 2016. “Asymptomatic” malaria: a chronic and debilitating infection that should be treated. PLoS Med 13: e1001942.
Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L, 2013. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther 11: 623–639.
Imwong M 2015. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J 14: 381.
Canier L 2015. Malaria PCR detection in Cambodian low-transmission settings: dried blood spots versus venous blood samples. Am J Trop Med Hyg 92: 573–577.
Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, Nosten F, Snounou G, White NJ, 2014. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol 52: 3303–3309.
Adams M 2015. An ultrasensitive reverse transcription polymerase chain reaction assay to detect asymptomatic low-density Plasmodium falciparum and Plasmodium vivax infections in small volume blood samples. Malar J 14: 520.
Lwin KM, Imwong M, Suangkanarat P, Jeeyapant A, Vihokhern B, Wongsaen K, Snounou G, Keereecharoen L, White NJ, Nosten F, 2015. Elimination of Plasmodium falciparum in an area of multi-drug resistance. Malar J 14: 319.
World Health Organization, 2011 . Malaria Rapid Diagnostic Test Performance: Results of WHO Product Testing of Malaria RDTs: Round 3 (2010–2011). Geneva, Switzerland: WHO.
Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK, 2009. Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol 47: 975–980.
Khairnar K, Martin D, Lau R, Ralevski F, Pillai DR, 2009. Multiplex real-time quantitative PCR, microscopy and rapid diagnostic immuno-chromatographic tests for the detection of Plasmodium spp.: performance, limit of detection analysis and quality assurance. Malar J 8: 284.
Bousema T, Okell L, Felger I, Drakeley C, 2014. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol 12: 833–840.
Tripura R 2016. Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies. Malar J 15: 181.
Shannon KL 2016. Subclinical Plasmodium falciparum infections act as year-round reservoir for malaria in the hypoendemic Chittagong Hill districts of Bangladesh. Int J Infect Dis 49: 161–169.
World Health Organization, 2015. World Malaria Report 2015: Summary. Geneva, Switzerland: WHO.
Wang RB, Zhang J, Zhang QF, 2014. Malaria baseline survey in four special regions of northern Myanmar near China: a cross-sectional study. Malar J 13: 302.
Xu JW, Liu H, Zhang Y, Guo XR, Wang JZ, 2015. Risk factors for border malaria in a malaria elimination setting: a retrospective case-control study in Yunnan, China. Am J Trop Med Hyg 92: 546–551.
Xu JW, Liu H, 2016. The relationship of malaria between Chinese side and Myanmar’s five special regions along China-Myanmar border: a linear regression analysis. Malar J 15: 368.